Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOYCE ANN O'SHAUGHNESSY

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1790727709
CMS profile
307682
Location
DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$321,923.38

167 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $76,853.61 19
Seagen Inc. $67,774.28 32
Merck Sharp & Dohme LLC $44,901.82 14
AstraZeneca Pharmaceuticals LP $23,894.54 18
Eli Lilly and Company $21,043.06 16
Stemline Therapeutics Inc. $17,408.34 9
F. Hoffmann-La Roche AG $14,428.43 5
NOVARTIS PHARMACEUTICALS CORPORATION $13,967.08 14
BioNTech SE $11,647.19 11
Amgen Inc. $6,814.50 1
Eisai Inc. $5,780.00 3
TerSera Therapeutics LLC $3,309.02 1
AstraZeneca UK Limited $3,107.66 4
Incyte Corporation $3,075.00 1
PFIZER INC. $2,137.07 4
Daiichi Sankyo Inc. $2,041.61 4
Gilead Sciences, Inc. $1,649.51 6
G1 Therapeutics, Inc. $1,000.00 1
Foundation Medicine, Inc. $865.00 1
Puma Biotechnology, Inc. $175.82 1
Genentech USA, Inc. $49.84 2

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

167 matching records · $321,923.38 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 167 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 167.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Seagen Inc. $7,920.0012/28/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995672689 CMS
Seagen Inc. $7,260.0012/28/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995672811 CMS
Seagen Inc. $59.5112/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995672819 CMS
Seagen Inc. $3,465.0012/22/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995672761 CMS
Daiichi Sankyo Inc. $1,995.0012/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006611707 CMS
Lilly USA, LLC $2,625.0012/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261031646831 CMS
AstraZeneca Pharmaceuticals LP $665.0012/18/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015869005 CMS
TerSera Therapeutics LLC $3,309.0212/15/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261052418805 CMS
Lilly USA, LLC $1,750.0012/14/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261031867467 CMS
Lilly USA, LLC $111.9912/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061275889 CMS
AstraZeneca Pharmaceuticals LP $1,712.5012/05/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015654255 CMS
Eli Lilly and Company $99.9912/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061275239 CMS
Stemline Therapeutics Inc. $124.3812/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040029367 CMS
Seagen Inc. $120.7811/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995672753 CMS
Merck Sharp & Dohme LLC $4,270.0011/22/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048274493 CMS
Lilly USA, LLC $6,125.0011/16/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261031610023 CMS
AstraZeneca UK Limited $1,662.5011/08/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016973757 CMS
Merck Sharp & Dohme LLC $6,100.0011/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048274495 CMS
Novartis Pharmaceuticals Corporation $23.4611/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026992729809 CMS
Novartis Pharmaceuticals Corporation $7.0410/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026992729805 CMS
Novartis Pharmaceuticals Corporation $11.3310/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026992729813 CMS
AstraZeneca Pharmaceuticals LP $3,325.0010/30/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015306419 CMS
F. Hoffmann-La Roche AG $7,980.0010/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040417659 CMS
F. Hoffmann-La Roche AG $659.3810/23/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040417669 CMS
F. Hoffmann-La Roche AG $89.0510/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040417675 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $1,400.0010/23/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026993423611 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $46.2210/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026993423613 CMS
Seagen Inc. $177.1810/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995672705 CMS
AstraZeneca UK Limited $70.1710/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016981107 CMS
Seagen Inc. $7,405.8510/22/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995672797 CMS
Seagen Inc. $150.6710/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995672711 CMS
AstraZeneca UK Limited $1,330.0010/16/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017047855 CMS
Merck Sharp & Dohme LLC $4,270.0010/11/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048274527 CMS
Stemline Therapeutics Inc. $21.2210/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040029377 CMS
AstraZeneca Pharmaceuticals LP $1,330.0010/01/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011684639 CMS
F. Hoffmann-La Roche AG $1,140.0010/01/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040417637 CMS
Stemline Therapeutics Inc. $3,900.0009/29/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040029358 CMS
Lilly USA, LLC $3,500.0009/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261031845139 CMS
Eisai Inc. $1,360.0009/27/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261023316961 CMS
PFIZER INC. $25.0009/26/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049440543 CMS
Gilead Sciences, Inc. $11.2309/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261026063289 CMS
AstraZeneca Pharmaceuticals LP $997.5009/05/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016229463 CMS
BioNTech SE $16.8009/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059908009 CMS
BioNTech SE $43.3609/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059908011 CMS
BioNTech SE $53.1209/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059908015 CMS
BioNTech SE $90.0009/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059908021 CMS
BioNTech SE $3,000.0009/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059908025 CMS
Stemline Therapeutics Inc. $1,950.0008/31/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040029371 CMS
Seagen Inc. $7,260.0008/29/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995672805 CMS
Amgen Inc. $6,814.5008/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020610541 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $229,965.22 168
PY2020 $143,165.92 83
PY2021 $219,820.94 100
PY2022 $179,312.78 107
PY2023 $321,923.38 167
PY2024 $117,051.40 101
PY2025 $132,489.71 131

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
JOYCE ANN O'SHAUGHNESSY, NPI 1790727709. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1790727709.
APA 7
IndustryPayments. (2026). JOYCE ANN O'SHAUGHNESSY, NPI 1790727709 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1790727709
Bluebook
JOYCE ANN O'SHAUGHNESSY, NPI 1790727709, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1790727709.

Source: Centers for Medicare & Medicaid Services, Open Payments.